Bruker Corp
NASDAQ:BRKR
Bruker Corp
NASDAQ:BRKR
Price:
74.33 USD
2.5%
Market Closed
Updated:
May 8, 2024
Bruker Corp
Operating Expenses
|
Bruker Corp
Operating Expenses Peer Comparison
Comparables:
TMO
DHR
WST
A
IQV
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bruker Corp
NASDAQ:BRKR
|
Operating Expenses
-$1B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-5%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Operating Expenses
-$9.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-10%
|
|
|
Danaher Corp
NYSE:DHR
|
Operating Expenses
-$16.1B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-10%
|
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Operating Expenses
-$426.5m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-5%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Operating Expenses
-$2.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Operating Expenses
-$3.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-14%
|
See Also
What is Bruker Corp's Operating Expenses?
Operating Expenses
-1B
USD
-1B
USD
Based on the financial report for Dec 31, 2023, Bruker Corp's Operating Expenses amounts to -1B USD.
What is Bruker Corp's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-5%
-5%
Over the last year, the Operating Expenses growth was -22%. The average annual Operating Expenses growth rates for Bruker Corp have been -15% over the past three years , -11% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
